Latest Breaking News On - Development of aruvirumab - Page 1 : comparemela.com

/PRNewswire/ Zalgen Labs LLC (Zalgen), a biotechnology and diagnostics company focused on high-impact, neglected infectious diseases, including Lassa Fever.

Robertf garryViral hemorrhagic fever immunotherapeutic consortiumDevelopment of aruvirumabUniversity of texas medical branch at galvestonTulane universityViral hemorrhagic fever consortiumNational academy of sciencesNational institutes of healthZalgen labsNational academyTexas medical branchLassa feverInvestigational new drugDrug administrationsZalgen managingWest africa